Stüve-Wiedemann syndrome: Long-term follow-up and genetic heterogeneity

Clinical Genetics

Volumn 77, Issue 3, 2010, Pages 266-272

  Jung, C ^a   Dagoneau, N ^a   Baujat, G ^a   Le Merrer, M ^a   David, A ^b   Di Rocco, M ^c   Hamel, B ^d   Megarbane A ^e   Superti Furga, A ^f   Unger, S ^f   Munnich, A ^a   Cormier Daire, V ^a  

^a UNIVERSITÉ PARIS DESCARTES   (France)

^b Nantes Hospital   (France)

^c G GASLINI INSTITUTE   (Italy)

^d RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^e SAINT JOSEPH UNIVERSITY   (Lebanon)

^f UNIVERSITY OF FREIBURG   (Germany)

Author keywords

Follow up; Genetic heterogeneity; LIFR; Long term; St ve; Wiedemann syndrome

Indexed keywords

LEUKEMIA INHIBITORY FACTOR RECEPTOR;

ADOLESCENT; ARTICLE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FOLLOW UP; GENE MUTATION; GENETIC VARIABILITY; HUMAN; MALE; MULTIPLE MALFORMATION SYNDROME; PRIORITY JOURNAL; STUVE WIEDEMANN SYNDROME; SURVIVOR;

ABNORMALITIES, MULTIPLE; FEMALE; FOLLOW-UP STUDIES; GENES, RECESSIVE; GENETIC HETEROGENEITY; HUMANS; LEUKEMIA INHIBITORY FACTOR RECEPTOR ALPHA SUBUNIT; MALE; OSTEOCHONDRODYSPLASIAS; SYNDROME;

EID: 77950106409     PISSN: 00099163     EISSN: 13990004     Source Type: Journal    
DOI: 10.1111/j.1399-0004.2009.01314.x     Document Type: Article

References (25)

1. Stuve A, Wiedemann HR. Congenital bowing of the long bones in two sisters. Lancet 1971, 2:495.
2. Cormier-Daire V, Munnich A, Lyonnet S. Presentation of six cases of Stuve-Wiedemann syndrome. Pediatr Radiol 1998, 28:776-780.
3. Cormier-Daire V, Superti-Furga A, Munnich A. Clinical homogeneity of the Stuve-Wiedemann syndrome and overlap with the Schwartz-Jampel syndrome type 2. Am J Med Genet 1998, 78:146-149.
4. Kozlowski K, Tenconi R. Stuve-Wiedemann dysplasia in a 3 1/2-year-old boy. Am J Med Genet 1996, 63:17-19.
5. Chen E, Cotter PD, Cohen RA. Characterization of a long-term survivor with Stuve-Wiedemann syndrome and mosaicism of a supernumerary marker chromosome. Am J Med Genet 2001, 101:240-245.
6. Di Rocco M, Stella G, Bruno C. Long-term survival in Stuve-Wiedemann syndrome: a neuro-myo-skeletal disorder with manifestations of dysautonomia. Am J Med Genet A 2003, 118A:362-368.
7. Superti-Furga A, Tenconi R, Clementi M. Schwartz-Jampel syndrome type 2 and Stuve-Wiedemann syndrome: a case for " lumping" Am J Med Genet 1998, 78:150-154.
8. Al-Gazali LI, Ravenscroft A, Feng A. Stuve-Wiedemann syndrome in children surviving infancy: clinical and radiological features. Clin Dysmorphol 2003, 12:1-8.
9. Giedion A, Boltshauser E, Briner J. Heterogeneity in Schwartz-Jampel chondrodystrophic myotonia. Eur J Pediatr 1997, 156:214-223.
10. Gaspar IM, Saldanha T, Cabral P. Long-term follow-up in Stuve-Wiedemann syndrome: a clinical report. Am J Med Genet A 2008, 146A:1748-1753.
11. Navarrete Faubel FE, Perez AA, Pastor Rosado J, Mascarell Gregoria A. Schwartz-Jampel syndrome type 2 versus Stüve-Wiedemann syndrome. An Esp Pediatr 2002, 56:473-474.
12. Reed UC, Reimao R, Espindola AA. Schwartz Jampel syndrome: report of five cases. Arq Neuropsiquiatr 2002, 60:734-738.
13. Reither M, Urban M, Kozlowski KS. Stuve-Wiedemann syndrome in two siblings: focusing on a male patient with the longest actual survival rate. Klin Padiatr 2006, 218:79-84.
14. Dagoneau N, Scheffer D, Huber C. Null leukemia inhibitory factor receptor (LIFR) mutations in Stuve-Wiedemann/Schwartz-Jampel type 2 syndrome. Am J Hum Genet 2004, 74:298-305.
15. Dagoneau N, Bellais S, Blanchet P. Mutations in cytokine receptor-like factor 1 (CRLF1) account for both Crisponi and cold-induced sweating syndromes. Am J Hum Genet 2007, 80:966-970.
16. Axelrod FB, Chelimsky GG, Weese-Mayer DE. Pediatric autonomic disorders. Pediatrics 2006, 118:309-321.
17. Ware CB, Horowitz MC, Renshaw BR. Targeted disruption of the low-affinity leukemia inhibitory factor receptor gene causes placental, skeletal, neural and metabolic defects and results in perinatal death. Development 1995, 121:1283-1299.
18. Kawasaki K, Gao YH, Yokose S. Osteoclasts are present in gp130-deficient mice. Endocrinology 1997, 138:4959-4965.
19. Bozec A, Bakiri L, Hoebertz A. Osteoclast size is controlled by Fra-2 through LIF/LIF-receptor signalling and hypoxia. Nature 2008, 454:221-225.
20. Nannenberg EA, Bijlmer R, Van Geel BM. Neonatal paroxysmal trismus and camptodactyly: the Crisponi syndrome. Am J Med Genet A 2005, 133A:90-92.
21. Crisponi L, Crisponi G, Meloni A. Crisponi syndrome is caused by mutations in the CRLF1 gene and is allelic to cold-induced sweating syndrome type 1. Am J Hum Genet 2007, 80:971-981.
22. Sohar E, Shoenfeld Y, Udassin R. Cold-induced profuse sweating on back and chest. A new genetic entity? Lancet 1978, 2:1073-1074.
23. Knappskog PM, Majewski J, Livneh A. Cold-induced sweating syndrome is caused by mutations in the CRLF1 gene. Am J Hum Genet 2003, 72:375-383.
24. DeChiara TM, Vejsada R, Poueymirou WT. Mice lacking the CNTF receptor, unlike mice lacking CNTF, exhibit profound motor neuron deficits at birth. Cell 1995, 83:313-322.
25. Li M, Sendtner M, Smith A. Essential function of LIF receptor in motor neurons. Nature 1995, 378:724-727.